Skip to content
Review

Polyendocrine Metabolic Ovarian Syndrome (PMOS; Formerly Polycystic Ovary Syndrome/PCOS) and Susceptibility to Microbial Infections: Mechanisms, Clinical Management, and Reproductive Consequences — A Comprehensive Review

Aug 2026 · Reproductive Sciences · Vol 33, pp. 1816 - 1837 · 0 citations · 170 references
Medicine

TL;DR

Evidence suggests that women with PMOS may be more vulnerable to selected infection-related conditions, especially vaginal dysbiosis, bacterial vaginosis, and vulvovaginal candidiasis, so clinical care should focus on established PMOS management, metabolic optimization, risk-based infection evaluation, and treatment of confirmed infections.

View source

Similar papers

Review Open access Aug 2026

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.

Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%-13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition...

M. Forslund, J. Melin, A. Joham et al. · 0 citations
Review Open access Aug 2026

Polycystic ovarian syndrome: an updated review of pathophysiology, clinical features, biomarkers, and management

Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age and represents a major global public health challenge. PCOS is a heterogeneous condition characterized by reproductive dysfunction, hyperandrogenism, insulin resistance (IR), and metabolic...

Blessy S. Joseph, D. B, K. Kumar · 0 citations
Review Open access Aug 2026

Polyendocrine Metabolic Ovarian Syndrome: A Brief Review.

Background: Polyendocrine metabolic ovarian syndrome (PMOS) is a prevalent endocrine disorder affecting 10-13% of reproductive-aged women. Characterized by hyperandrogenism, ovulatory dysfunction, and metabolic disturbances, its management is increasingly focused on the gut-brain-ovary axis and chronic low-grade inflam...

Samia Bennani, Karen Foote · 0 citations
Review Jul 2026

Polycystic ovary syndrome and insulin resistance: A focus on pathogenesis, risk factors, and therapeutic strategies.

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder characterized by significant reproductive and metabolic complications. Insulin resistance (IR) plays a central role in the pathophysiology of PCOS and contributes to several associated metabolic abnormalities. This review highlights the key mechanisms unde...

J. Singla, Shubhi Yadav, J. Gayen · 0 citations
Review Open access Jan 2026

Gut Microbiome‐Targeted Preventive Strategies for Polyendocrine Metabolic Ovarian Syndrome: Insights From the Prenatal and Early‐Life Environment

ABSTRACT Background Polyendocrine metabolic ovarian syndrome (PMOS), the proposed new name for polycystic ovary syndrome (PCOS), is a complex endocrine and metabolic disorder influenced by genetic and environmental factors. Despite its high prevalence and familial aggregation, no effective preventive strategy is availa...

A. Kusamoto, Yutaka Osuga, Y. Hirota et al. · 0 citations
Review Open access Sep 2026

The role of intestinal microbial metabolites in polycystic ovary syndrome: mechanistic insights and intervention prospects

Polycystic ovary syndrome (PCOS) is a prevalent endocrine-metabolic disorder among women of reproductive age, defined by the core features of hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. PCOS is frequently complicated by insulin resistance, obesity, dyslipidemia, and chronic low-grade...

Ye Gao, Lin-Lin Fan, Rui Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.